Larimar Therapeutics Raises $172.5 Million in Public Offering to Propel Rare Disease Research
BALA CYNWYD, PA — The biotech firm Larimar Therapeutics, Inc. (Nasdaq: LRMR) recently announced that it has successfully closed an underwritten public offering. The company sold 19,736,842 shares of its …
Larimar Therapeutics Raises $172.5 Million in Public Offering to Propel Rare Disease Research Read More